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Directed by: Dr. Eric A. Decker 
Polyunsaturated omega-3 fatty acids (n-3 PUFAs) have been suggested to reduce risk for 
multiple diseases but animal studies on the beneficial effects of n-3 PUFAs are conflicting, 
possibly due to the presence of toxic lipid oxidation products in the oils used in these studies. In 
order to provide guidance for future research in n-3 PUFA supplementation, this study 
researched lipid oxidation and its inhibition in an animal feed system enriched with fish oil. 
Different storage conditions were tested, and it was found that samples stored at room 
temperature or above were at significant risk for oxidation with lag phases of propanal formation 
being 56, 8 and 2 days at 4°C, 23°C and 37°C. More than 65% removal of oxygen was needed to 
significantly decrease lipid oxidation.  Greater than 65% removal of oxygen could be achieved in 
less than 1 minute of nitrogen flushing. Tocopherols were not strong antioxidants in the animal 
feed but Trolox was, suggesting that the fish oil enriched rodent feed acts similarly to bulk oil. 
Both ascorbic acid and ascorbyl palmitate were found to be ineffective, possibly due to their 
prooxidant activity. In a comparison of propyl gallate (PG), butylhydroxy toluene (BHT), and 
tert-butylhydroquinone (TBHQ), results were found similar to other low-moisture systems, with 
PG being prooxidative, BHT improving lag phase, and TBHQ having a significant impact on lag 
phase. These results suggest that lipid oxidation products can be present at the start of a dietary 
omega-3 fatty acid study if poor quality oils are used and that oxidation can occur in the feed 
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during storage times common to animal studies.  These findings indicate that researchers should 
use antioxidant strategies to control oxidation in animal feeds to avoid potentially conflicting 
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 The reported health benefits of unsaturated fatty acids and recommendations to reduce 
the saturated fat content of foods has increased interest in consuming omega-3 polyunsaturated 
fatty acids (n-3 PUFAs). Of these fats, long-chain eicosapentaenoic acid (EPA) and 
docosahexanoic (DHA) fatty acids have been observed to have the strongest positive impact on 
human health. While work has been done on obtaining these fatty acids from other marine 
sources such as algae, their primary dietary source is fish. Other potentially beneficial omega-3 
polyunsaturated fatty acids can be obtained from vegetable fats, such as flaxseed oil. A great deal 
of literature suggests that an increased intake of these lipids helps to reduce the risk for multiple 
disease, including cancers and cardiovascular disease, among others.  
 
1.2 Dietary Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease 
 
 The largest and most heavily supported beneficial effect associated with n-3 PUFAs is its 
impact on cardiovascular disease risk (Arab-Tehrany 2012, Mori 2017, Saravanan et al. 2010). 
The literature is strong enough that the American Heart Association released a scientific 
statement encouraging its consumption (Siscovik et al. 2017). Epidemiological evidence, while 
not consistent, generally suggests an inverse between n-3 PUFA consumption and cardiovascular 
disease risk. For example, while Hu et al. (2002) found that higher fish consumption led to a 
lower risk of coronary heart disease and a similar result was found for omega-3 fatty acid intake 
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after a 12-year follow-up, Osler et al. (2003) found no association between fish consumption and 
coronary heart disease. The supporting evidence is enough, though, that a great deal of research 
has been performed to elucidate these supposed beneficial effects. 
 
1.2.1 Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease in vitro and in 
Animals 
 
Both in vitro and animal models allow insight into the potential mechanisms through 
which dietary n-3 PUFAs may be exerting their beneficial effects observed epidemiologically. 
De Caterina et al. (2000) linked the consumption of DHA with antiatherogenic and anti-
inflammatory properties through the ability of DHA to alter the expression of adhesion 
molecules in vitro. Introduction of DHA to adult rat cardiomyocytes was observed to 
significantly reduce lysophosphatidylcholine-induced spontaneous contractions (Leifert et al. 
2000). The authors suggested that the mechanism of this prevention was linked to changes of 
membrane fluidly induced by DHA (Leifert et al. 2000). In adult guinea pig ventricular myocytes 
with sodium ion currents blocked, Ferrier et al. (2002) showed that DHA was able to inhibit 
Ca2+ influx while preserving cardiac contractile function, providing an antiarrhythmic effect. 
Xiao et al. (2004) found that EPA inhibited outward and inward sodium-calcium exchanger 
current in HEK293t cells, showing one of the possible protective effects of EPA against fatal 
arrhythmias. In hydrogen peroxide induced DNA damage in human aortic and endothelial cells, 
both EPA and DHA treatment were able to reduce DNA damage and did so through upregulation 
of the NRF2-mediated antioxidant response (Sakai et al. 2007). In myocytes from both rabbits 
and patients with heart failure, fish oil superfusion was found to inhibit triggered arrhythmias 
(Ruijter et al. 2008).  
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 Similar functionality has been observed in animals. Dhein et al. (2005) found an 
antiarrhythmic effect of dietary DHA and EPA when infusing the fatty acid in spontaneously 
beating isolated rabbit hearts. Similarly, Dujardin et al. (2008) showed that DHA was able 
provide an ultrafast sodium channel block, which protected against dofetilide-induced 
arrhythmia. In a porcine infarct model, pericardial infusion of DHA was shown to reduce 
malignant arrhythmias, heart rate, and infarct sizes (Xiao et al. 2008). Rats fed two different high 
fat n-3 PUFA rich sources, a microalgal source and a fish oil source, showed reduced 
insulinemia and serum lipid levels compared to a control, after 8 weeks of treatment (Haimeur et 
al. 2016).  In type-2 diabetic and dyslipidemic primates given n-3 PUFAS, Hals et al. (2017) 
observed that n-3 PUFA treatment had a positive effect on cardiovascular disease risk factors, 
such as reducing total cholesterol, LDL-cholesterol, and triglycerides while increasing HDL-
cholesterol.  
The results are not consistent between studies. For example, in hearts isolated from pigs 
that had received a n-3 PUFA diet, Coronel et al. (2007) observed that the fish oil was 
proarrhythmic compared to the control group during regional ischemia. An important 
consideration for n-3 PUFA enrichment both in comparing different studies and for human 
therapy is the differences in cardiovascular health of the subject. In pigs, a fish oil diet was 
observed have both pro and antiarrhythmic effects (Verkerk et al. 2006). Thus, the authors 
concluded that the pathophysiological setting is important for determining the effectiveness of n-






1.2.2 Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease in Humans 
 
There is strong experimental evidence that dietary intake of n-3 PUFAs reduces 
cardiovascular disease risk. In the JELIS Trial, 18645 Japanese hypercholesterolaemic patients 
were fed either 1800 mg of EPA daily with statin or just statin for five years (Yokoyama et al. 
2007). The EPA treatment was found to reduce major coronary events, both fatal and non-fatal 
(Yokoyama et al 2007). Guillot et al. (2009) observed 12 healthy men given different 
concentrations of DHA to consume. During the course of the study, DHA was present in platelet 
phospholipids in a dose dependent manner and low consumption of DHA displayed an 
antioxidant effect (Guillot et al. 2009). Bannikoppa et al. (2017) also found a correlation between 
dietary n-3 PUFA and erythrocyte n-3 PUFA. 
Ready incorporation of DHA and EPA into atherosclerotic plaques is one potential 
explanation for the beneficial effects of n-3 PUFAs on cardiovascular disease. In patients 
awaiting carotid endarterectomy, fish oil supplementation led to an increase in EPA and DHA in 
carotid plaque fractions, a decrease in the signs of inflammation, and fewer thick fibrous caps 
macrophages in the plaques (Thies et al. 2003). The positive effect of n-3 PUFAs on health has 
also been closely associated lipid metabolism. DHA supplementation for 45 days in 
hypertriglyceridemic men was found to decrease fasting triacylglycerol, large VLDL, IDL while 
increasing concentration of large LDL particles (Kelley et al. 2007). The authors concluded that 
this change can improve health by reducing triacylglycerol and small, dense LDL particles 
(Kelley et al. 2007). Similarly, Milte et al. (2008) found that DHA supplementation decreased 
serum triacylglycerol while increasing both HDL and LDL cholesterol in a dose dependent 
manner. Erythrocyte DHA concentration increased in a dose dependent manner. Beneficial 
decrease in triacylglycerol correlated with rise in erythrocyte DHA (Milte et al. 2008).  
5 
 
 Not all human studies have found a beneficial effect of n-3 PUFAs consumption. In the 
Rotterdam Study, intakes of EPA, DHA, and fish had no association with atrial fibrillation risk, 
the most common sustained cardiac arrhythmia (Brouwer et al. 2006). Rauch et al. (2010) found 
that omega-3 fatty acid supplementation was unable to reduce the rate of sudden cardiac death 
and other clinical events in survivors of acute myocardial infarction who were also being given 
guideline-adjusted treatment. In a prospective cohort study in women, Rhee et al. (2017) found 
no association between risk of major cardiovascular disease and intake of tuna, dark fish, α-
linolenic acid, or marine omega-3 fatty acids. Garcia-Alonso et al. (2012) fed healthy women 
tomato juice enriched with n-3 PUFAs and found no impact of the supplementation on lipid 
profile. Mozaffarian et al. (2012) observed the impact of perioperative n-3 PUFA 
supplementation in patients scheduled for cardiac surgery and found no influence of n-3 PUFAs 
on postoperative atrial fibrillation. Patients with dysglycemia and at high risk for cardiovascular 
events were given n-3 fatty acids, but the intervention had no significant impact on 
cardiovascular death, death from any cause, major vascular events, or death from arrhythmia 
(Bosch et al. 2012). In patients with multiple cardiovascular risk factors, daily treatment of n-3 
fatty acids was shown to have no significant impact on cardiovascular mortality and morbidity 
(Roncaglioni et al. 2013). As observed in animal models, this difference in results may be due to 
the differing disease states being researched. Another possibility that has not been focused upon 
in the current literature is the possibility of the treatment fats being oxidized. Lipid oxidation can 
lead to the formation of toxic products which may lessen the potential benefits of n-3 PUFA 





1.3 Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 
 
1.3.1 Omega-3 Polyunsaturated Fatty Acids and Cancer in vitro and in Animals 
 
In vitro research suggests that n-3 PUFAs are able to reduce the negative impact of 
cancer, primarily through induction of apoptosis and altering gene expression in cancer cells. 
The proapoptotic influence of n-3 PUFAs, specifically DHA, has been shown in many different 
cancer cell models. Treatment of human colorectal cancer cells with DHA induced apoptosis and 
was shown to do so through proteasomal regulation of β-catenin levels and expression of TCF-β-
catenin target genes (Calviello et al. 2007). In lung cancer cells, DHA treatment was found to 
induce apoptosis and involved a phosphatase activity (Serini et al. 2008). The ability of DHA to 
increase apoptosis has also been observed in human melanoma cells, human breast cancer cells, 
and human prostate cancer cells (Serini et al. 2012, Sun et al. 2011, Hu et al. 2010). In human 
breast cancer cell lines, both DHA treatment and EPA treatment were shown to inhibit 
proliferation and invasion of breast cancer cells, but DHA was more effective than EPA 
(Rahman et al. 2013).  
Most cancer research on the effect of n-3 PUFAs has been in rodents with tumorigenesis 
induced either by genetics or the introduction of carcinogens. N-3 PUFAs have been observed to 
have a positive effect in multiple different cancers in animals. For example, in azoxymethane-
induced colon cancer in rats, rats on a diets of flaxseed oil showed a reduced incidence of 
aberrant crypt foci (Williams et al. 2007). Diets of omega-3 fatty acids also reduced tumor load 
in colon cancer induced rats (Gutt et al. 2007). In colorectal cancer induced mice, Hawcroft et al. 
(2012) observed that EPA supplementation reduced tumor weight, tumor cell proliferation, and 
metastasis. Other cancer models have found similar results. Bose et al. (2007) provided 
ApcMin/+ mice with diets containing 20% (w/w) fish oil and found a reduction in the number of 
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large tumors. Berquin et al. (2007) used prostate-specific Pten-knockout mice fed an omega-3 
enriched diet and found that the diet reduced prostate tumor growth, slowed histopathological 
progression, and increased survival compared to the control group. A diet containing n-3 PUFAs 
was observed by Hu et al. (2010) to lessen the progression of prostate cancer malignancy in 
mice. Strouch et al. (2011) provided (EL)-Kras transgenic mice with a high omega-3 fat diet and 
the diet reduced markers of cell proliferation in precancerous tumors of induced pancreatic 
cancer. Gleissmann et al. (2011) found that DHA by gavage was able to inhibit growth of 
established neuroblastomas in nude rats but dietary DHA was unable to, likely due to a slower 
accumulation of DHA when obtained from food. In athymic mice with intra-cardiac injection of 
breast cancer cells, DHA treatment significantly lowered breast cancer cell metastasis (Rahman 
et al. 2013). 
 
1.3.2 Omega-3 Polyunsaturated Fatty Acids and Cancer in Humans  
 
 Research on dietary omega-3s in humans is conflicting and limited compared to the 
research in other models. Thus, the impact of dietary n-3 PUFAs on cancer in humans is still 
unclear (Song et al. 2014). Arem et al. (2013) found that higher intakes of EPA and DHA were 
significantly associated with lower risk for endometrial cancer, as was the use of fish oil 
supplements. In a 9-year follow-up study, Sasazuki et al. (2013) found associations that 
suggested marine n-3 PUFAs may be inversely related to colon cancer risk, but only in the 
proximal site of the large bowel. In a case-cohort analysis of women with or without breast 
cancer, Bassett et al. (2016) found that breast cancer risk was inversely associated with dietary 
DHA and EPA, while breast cancer risk was positively associated with saturated fat intake and 
omega-6 fatty acids. In women with newly diagnosed breast, cervical, or ovarian cancer, 
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Bannikoppa et al. (2017) found that patients with malignancies had significantly lower overall 
intakes of linoleic acid and long chain n-3 PUFAs. In addition, the erythrocytes of the cancer 
group had lower linoleic acid compared to controls (Bannikoppa et al. 2017). Contrasting with 
this evidence, Chajés et al. (1999) found no association between serum n-3 PUFAs and breast 
cancer risk in a comparison of the pre-diagnostic sera of women who later developed breast 
cancer. Song et al. (2014) found no overall association between fish, omega-3, or omega-6 
PUFAs and colorectal cancer risk in a 26-year long follow-up study. But, marine omega-3 PUFA 
did have an inverse association with risk of distal colon and rectal cancer in men (Song et al. 
2014). 
In addition to associations between dietary n-3 PUFAs and cancer development, patients 
recovering from or currently diagnosed with cancers have been a target for research. Similar to 
other cancer literature, the results are not consistent (Eltweri et al. 2017, Gleissman et al. 2010, 
Mourouti et al. 2015). In colorectal cancer patients undergoing chemotherapy, supplementation 
with fish oil for 9 weeks positively impacted markers for inflammatory and nutritional status 
(Silva et al. 2012). Fish oil was found to prevent decreases in neutropenia in patients receiving 
chemotherapy after surgical tumor removal (Bonatto et al. 2012). Torrinhas et al. (2013) found 
that fish oil-based lipid emulsions provided post-operative immunological benefits to 
gastrointestinal cancer patients prior to surgery. This result conflicts, however, with observations 
by Makay et al. (2011), who found that supplementation with n-3 PUFAs after major gastric 
cancer surgery had no impact on biochemical parameters, complications, length of hospital stays, 
or mortality. Sultan et al. (2012) also observed no change clinical outcomes for oesophagogastric 
cancer patients given a n-3 PUFA enteral immunoenhancing diet 7 days before and after surgery. 
(Sultan et al. 2012). 
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1.4 Dietary Omega-3 Polyunsaturated Fatty Acids and Other Diseases 
 
1.4.1 Epidemiological Evidence for Omega-3 Polyunsaturated Fatty Acids and Various 
Diseases 
 
While there has been considerable research in cardiovascular disease and cancer, other 
diseases have been studied as well, guided by epidemiological evidence. For example, n-3 
PUFAs may positively affect health by increasing insulin sensitivity. Rats fed fish oil and algal 
oil have been observed to have reduced insulinemia (Haimeur et al. 2016). In a follow-up study 
in normoglycemic elderly men and women, higher fish intake was associated with a significantly 
reduced incidence of glucose intolerance (Feskens et al. 1991). This observation is supported by 
a study by Browning et al. (2007), where individuals with a raised inflammatory status were 
given DHA and EPA supplements. The authors found that the n-3 PUFA treatment increased 
insulin sensitivity (Browning et al. 2007). However, in a dietary intervention study where 
saturated fat was replaced isoenergetically with long chain n-3 PUFAs, Tierney et al. (2010) 
found that there was no effect on insulin sensitivity in weight-stable individuals but did find a 
decrease in plasma triglycerides.  
n-3 PUFAs have also been linked to depressive disorders. In the Hordaland health study, 
Raeder et al. (2007) found that users of cod liver oil supplements had a lower likelihood of 
having depressive symptoms. In a metaanalysis, Kraguljac et al. (2009) concluded that omega-3 
fatty acids are a potential treatment for depressive disorders, but not for mania. Compared to 
healthy elderly subjects, those with depression were observed to have significantly lower n-3 
PUFA concentration in their erythrocyte membranes (Rizzo e al. 2012). Supporting these 
observations, Rizzo et al. (2012) showed that n-3 PUFA supplementation reduced depression 
symptoms in elderly subjects.   
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Similarly, n-3 PUFAs have been suggested to have an impact on cognitive impairment 
and Alzheimer’s Disease (Fotuhi et al. 2009, McNamara 2016). Low serum DHA has been 
associated with an increased risk for the development of Alzheimer’s Disease (Kyle et al. 1999). 
High fish consumption has been associated with a decrease in cognitive impairment, a decrease 
in cognitive decline, and a decreased risk for the development of Alzheimer’s Disease (Larrieu et 
al. 2004). The use of omega-3 rich oils has also been associated with a decreased risk for all-
cause dementia (Barberger-Gateau et al. 2007). Milte et al. (2011) found that older adults with 
mild cognitive impairment had lower erythrocyte EPA. The current literature is in conflict, 
however, as to the applicability of these observations. While human subjects with mild cognitive 
disfunction given arachidonic acid and DHA supplementation for 90 days showed improvement 
in immediate memory and attention according to Kotani et al. (2006), van de Rest et al. (2008) 
observed no benefit of DHA and EPA supplementation in cognitively healthy individuals.  
 
1.4.2 The Anti-inflammatory Effect of Omega-3 Polyunsaturated Fatty Acids as a Disease 
Reduction Mechanism 
 
 The inflammatory response is implicated in the progression of many diseases. The 
potential antinflammatory effect of n-3 PUFAs is one explanation of its ability to delay the onset 
of multiple diseases (Calder 2013, Rangel-Huerta et al. 2012, Singer et al. 2008). In vitro 
evidence strongly supports the antiinflammatory effect of n-3 PUFAs. In ultraviolet-B radiation 
induced inflammation in mouse skin, topical application of DHA lowered inflammation by 
inhibiting the activation of NF-kB (nuclear factor κB) and the expression of COX-2 and NOX-4, 
all of which play important roles in provoking inflammation and inducing oxidative stress 
(Rahman et al. 2011). After initiating the inflammatory response in human macrophages with 
lipopolysaccharide, Matinez-Micaelo et al. (2012) found that DHA prevented the activation of 
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the NF-κB cellular cascade, decreasing the release of proinflammatory NF-κB-regulated agents 
such as cytokines and prostaglandins. Oliver et al. (2012) pretreated macrophages with either 
EPA or DHA before exposing the cells to lipopolysaccharide to induce inflammation. The 
authors found that DHA was more effective than EPA and that both reduced the activation of 
NF-κB activation and tumor necrosis factor (TNF)α secretion. 
 Positive results have been observed for n-3 PUFA supplementation and inflammatory 
markers, primarily in individuals with a disease state. In overweight women with high levels of 
inflammation, n-3 PUFA treatment increased plasma EPA and DHA, lowered serum 
triglycerides, and lowered inflammatory markers (Browning et al. 2007). Zhao et al. (2009) 
displayed that in patients with heart failure, n-3 PUFA supplementation for 3 months was able to 
reduce multiple inflammatory markers significantly. In patients with systemic inflammatory 
response syndrome, Barbosa et al. (2010) showed that fish oil administered to the peritoneum 
increased plasma EPA, modified inflammatory cytokine concentration, and decreased hospital 
stay length. As n-3 PUFAs impact inflammatory pathways, they may have a positive impact on 




 There is a considerable amount of research investigating the beneficial effects of omega-3 
polyunsaturated fatty acids, especially on the impact of EPA and DHA. While observations in 
humans are conflicting, there is a great deal of research that shows a beneficial effect of dietary 
n-3 PUFAs on lipid metabolism, which in turn leads to a decrease in cardiovascular disease risk. 
Mechanisms have been researched as well, elucidating the effect of n-3 PUFAs on lipid 
metabolism and arrhythmias. Their ingestion may also have an impact on decreasing the risk for 
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cancer and other diseases. Dietary omega-3 polyunsaturated fatty acids have been linked heavily 
with an anti-inflammatory effect, which may explain its multiple health benefits. Within human 
and animal studies there is some conflicting evidence. Variation in model, especially in disease 
state, in dose volume, time frame, and fatty acid profile are all factors that can lead to this 
conflict.  The presence of lipid oxidation products in the n-3 PUFA supplementation is another 
potential explanation, however, that has not been heavily addressed in the current literature. 
More research is needed in order to better elucidate the benefits, their mechanisms, and proper 










 Highly unsaturated oils, especially those from marine sources, are an important topic of 
research. The U.S. Department of Health and Human Services and U.S. Department of 
Agriculture 2015-2020 dietary guidelines suggest replacing solid fats with unsaturated oils. 
Consumption of polyunsaturated fats, especially omega-3 polyunsaturated fatty acids (n-3 
PUFAs), is recommended due to the potential health benefits. Thus, there is a great desire to 
introduce more unsaturated fats into the diet, through both food products and dietary 
supplements. The main downside of using highly unsaturated fats is that they are significantly 
more prone to lipid oxidation. In addition to causing problems with consumer acceptance and 
overall quality, lipid oxidation may lessen the health benefits of n-3 PUFAs and could even lead 
to toxicity.    
 
2.2 Mechanisms of Lipid Oxidation 
 
The process of lipid oxidation is a thoroughly researched and reviewed group of chemical 
reactions, thoroughly described in other works (Brady 2012, Girotti 1985, McClements and 
Decker 2008). In summary, lipid oxidation is defined by three phases: initiation, propagation, 
and termination. The first step of the process, initiation, occurs when a hydrogen is removed 
from an unsaturated fatty acid, leading to the production of an alkyl radical (R●). The 
susceptibility of a fatty acid to hydrogen removal increases as the degree of unsaturation 
increases (Holman and Elmer 1947, Martín-Polvillo et al. 2004). For example, Martín-Polvillo et 
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al. (2004) tested sunflower oils of differing unsaturation degree and found that the rate of 
oxidized triglyceride monomers and peroxide formation and the amount of total oxidized 
triglycerides and peroxides were higher the more unsaturation was present. Thus, the likelihood 
of an oil becoming oxidized increases with increased double bonds. Lipid oxidation is also 
expedited by factors such as transition metals, enzymes, photosensitizers, high temperatures, and 
irradiation, all of which tend to promote the creation of free radicals or reactive oxygen species. 
After the removal of a hydrogen, the fatty acid isomerizes to form a conjugated double 
bond. Afterward, propagation begins as atmospheric oxygen is added and forms a peroxyl radical 
(ROO●). Peroxyl radicals are reactive enough to remove hydrogens from other unsaturated fatty 
acids, leading to a new alkyl radical (R●) and a lipid hydroperoxide (ROOH). Β-scission 
reactions lead to the decomposition of lipid hydroperoxides into alkoxyl radicals (RO●). These 
new radicals introduce another means of attacking unsaturated fatty acids and causes an 
exponential increase in oxidation rate. Β-scission reactions break covalent bonds within the 
hydrocarbon chain and form low molecular weight compounds such as aldehydes, shorter 
hydrocarbons, and ketones. These smaller products are volatile and cause rancid odors. Other 
reactions follow β-scission reactions as well, including reacting with other components of the 
food, performing Michael additions, or Schiff’s base reactions.  
Termination occurs when two radicals react with one another to form a non-radical 
product. This reaction is often not relevant in foods. A food is already rancid before these 
reactions take place. The period prior to the exponential gain of lipid oxidation products is 
defined as the lag phase, or as the period before which there is no significant change in oxidation 
product amount. This period, where oxidation products are accumulating slowly, is the primary 
target of research and observation, and the focus of research in many foods and other oxidizable 
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systems is to extend the lag phase. It is during lag phase that products responsible for rancid 
odors are below sensory thresholds. As food is effectively rancid when the lag phase ends, it is 
the best representation of shelf life.  
 
2.3 Lipid Oxidation Products in in vitro Studies   
 
In vitro research suggests that lipid oxidation products are able to be taken up by 
intestinal cells and can exert an effect on lipid metabolism. Using human colonic CaCo-2 cells, 
Wang et al. (2000) found that subtoxic concentrations of lipid hydroperoxides increased cell 
apoptosis and disrupted redox homeostasis. Addition of hydroperoxy fatty acids to a CaCo-2 cell 
monolayer was shown to disrupt lipid metabolism and allowed their incorporation into more 
complex lipids, potentially leading to oxidizable lipoproteins (Muller et al. 2002). Penumetcha et 
al. (2002) showed that the presence of an oxidation product of linoleic acid enhanced the serum 
solubility of cholesterol and its uptake in CaCo-2 cells. As lipid oxidation products have an 
impact on cellular metabolism, they may affect human health. 
2.4 Lipid Oxidation Products in Animal Studies 
Ingestion of lipid oxidation products has been associated with multiple diseases in 
animals including inflammation, certain cancers, and cardiovascular disease (Turner et al. 2006). 
The largest impact of oxidized lipid ingestion has been observed in lipid metabolism and 
atherosclerosis. In both control and diabetic rats, feeding of oxidized lipids was observed to 
increase the quantity of peroxides in serum lipoproteins, and the effect was more dramatic when 
the animals were diabetic (Staprans et al. 1993). In low density lipoprotein (LDL) receptor and 
apolipoprotein E deficient mice fed either cholesterol or cholesterol with 5% oxidized 
cholesterol, Staprans et al. (2000) observed that the diets with oxidized cholesterol led to the 
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appearance of oxidized cholesterol in the serum. In addition, the authors found an increase in 
fatty streak lesions in mice fed oxidized cholesterol. In rats, Penumetcha et al. (2002) found that 
an oxidation product of linoleic acid increased the uptake of cholesterol and thus could lead to 
hypercholesterolemia and atherosclerosis. Keller et al. (2004) showed that erythrocytes of 
Guinea pigs fed oxidized fat were more susceptible to haemolysis in vitro and had reduced 
antioxidant content compared to a control diet. These studies suggest that not only are oxidized 
lipids absorbable from the diet, they cause a significant impact on lipid metabolism. The 
increased uptake of cholesterol and presence of oxidized lipids in chylomicrons suggests that 
lipid oxidation can play a role in atherogenesis, likely through a buildup of cholesterol and an 
increase in LDL oxidation.  
Specific lipid oxidation products have been researched in animals as well. 
Crotonaldehyde, a representative α, β-unsaturated carbonyl compound, is considered to be 
genotoxic, mutagenic, and carcinogenic (Eder and Budiawan 2001). For example, 
crotonaldehyde was shown to significantly increased liver tumors in rats when added to drinking 
water (Chung et al. 1986). After 4 weeks of intake of crotonaldehyde in food in rats, Eder and 
Budaiwan (2001) found that 1,N2-propanodeoxyguanosine DNA adduct increased and persisted 
to some extent. Acrolein is another α,β-unsaturated carbonyl compound produced in foods from 
lipid oxidation. Mice given oral acrolein showed a significant increase in myocardial infarct size 
and acrolein was found to target mitochondria (Wang et al. 2008). Acrolein fed mice were also 
shown to have increased signs of myocardial oxidative stress, nitrative stress and in the heart, 
signs of physical translocation of ingested acrolein (Ismahil et al. 2011). 
Some animal studies, however, have found a lack of oxidized lipid inducing general toxic 
symptoms. In miniature pigs fed thermally oxidized lipids, Eder and Stagl (2000) found no 
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difference in plasma clinicochemical variables. Eder et al. (2003) gave rats diets of fresh or heat 
oxidized fat and found that LDL in heat treated fat diet were more susceptible to oxidation, but 
the uptake of LDL by macrophages were unaffected and thus did not adversely affect the 
lipoprotein profile. 
 
2.5 Lipid Oxidation Products in Human Studies 
 
Research in humans suggests that lipid oxidation products are absorbed into the serum 
and may affect health. Human chylomicrons obtained after ingestion of thermally oxidized fat 
were shown to be rich in lipid peroxides and the authors observed an accumulation of cholesterol 
when the chylomicrons introduced to murine macrophages (Naruszewicz et al. 1987). Staprans et 
al. (1994) researched the impact of oxidized lipid ingestion on oxidized lipid level of 
postprandial serum chylomicrons and found that conjugated diene content increased significantly 
in chylomicrons after the consumption of highly oxidized corn oil. Partially oxidized oil also led 
to an increase of conjugated diene content, but not as large of an increase (Staprans et al. 1994). 
In addition, consumption of a meal containing used cooking fat, a source of lipid oxidation 
products, was found to increase in indicators of impaired arterial endothelial function compared 
to meal of fresh fat and a low-fat meal (Williams et al. 1999). In a study of healthy women aged 
roughly 40 years given fat containing hydroxy or dihydroxy triglycerides to consume, Wilson et 
al. (2002) showed that the lipid oxidation products were absorbed into the serum. In a 
comparison of postprandial inflammation markers after consumption of either pan fried beef or 
sous vide beef, Nuora et al. (2015) concluded that oxidized lipids have the ability to impact 
postprandial oxidative stress and inflammation.  As oxidized lipids may be taken up by the small 
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intestine and packaged into chylomicrons, they can further lead to oxidized LDL, which are more 
atherogenic (Esterbauer 1993).  
While many studies suggest that lipid oxidation products are absorbed and influence 
oxidative stress and other metabolic factors, the results are not consistent (Baynes 2007). One 
such study was performed by Ottestad et al. (2012), where the authors measured markers of 
oxidative stress, lipid peroxidation, inflammation, and plasma omega-3 fatty acids in humans 
after intake of 8g/day oxidized or unoxidized fish oil and found no change in these markers 
between the two groups after consumption for 3 or 7 weeks. 
Due to the conflicts in animal and human studies, the toxicity of lipid oxidation remains 
an active area of research. There is, however, a great deal of evidence that suggests that lipid 
oxidation products are absorbed, and mechanisms have been displayed for their negative impact 
on health. Thus, the toxicity of lipid oxidation is still a concern, especially in products enriched 
with unsaturated fats, where lipid oxidation is more common. They are also a concern in studies 
on the health impact of dietary n-3 PUFAs, as their presence may cause negative health effects if 
not controlled for. 
 
2.5 Conclusions  
 
 As the desire to consume polyunsaturated fats for their health benefits increases, so has 
the amount of research on lipid oxidation. Lipid oxidation presents a huge problem as the 
polyunsaturated fatty acid content of food and dietary supplements increases. As these fats are 
far more susceptible to lipid oxidation, understanding the mechanisms of lipid oxidation and its 
control are important. Lipid oxidation is influenced by many factors, including antioxidant 
addition, temperature, and oxygen concentration, which have received a great deal of research. 
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While there is substantial evidence that suggests that lipid oxidation products may exert a toxic 
effect in both animals and humans, the overall results are unclear. More research is needed in the 
field of lipid oxidation in order to safely recommend dietary enrichment of polyunsaturated fats, 






LIPID OXIDATION IN ANIMAL FEED ENRICHED WITH FISH OIL 
 
3.1 Introduction  
 
Omega-3 fatty acids have been touted for their potential health benefits including 
reducing risk for cardiovascular disease, inflammation, and cancer. However, studies on the 
extent of these benefits in animal models are often conflicting (Fotuhi et al. 2009, McNamara 
2016, Verkerk et al. 2006). Lipid oxidation rates increase with increasing level of unsaturation, 
thus omega-3 fatty acids with their 3-6 double bonds are extremely susceptible to oxidation. 
Lipid oxidation leads to the destruction of vital vitamins, such as vitamin A and E (Kubow 1992) 
and also results in the formation of numerous potentially harmful lipid oxidation products. As 
lipid oxidation could potentially cause a negative impact on animal health, it may be a 
confounding variable in dietary omega-3 fatty acids animal studies, making data interpretation in 
animal models difficult if precautions are not taken to insure both good starting oil quality and 
that lipid oxidation does not occur during feeding studies.  
There is a dearth of research on the biological activities of the lipid oxidation products of 
n-3 PUFAs and ingestion of lipid oxidation products has been observed to have a negative 
impact on health (for review see Wang et al. 2017). Lipid oxidation products can survive 
digestion and thus they may be absorbed from a meal containing both unoxidized or oxidized 
omega 3 fatty acids (Goicoechea et al. 2011). Many different oxygenated α, β-unsaturated 
aldehydes are formed from lipid oxidation and they have been shown to have various degrees of 
toxicity. Examples lipid oxidation products formed from n-3 PUFAs include 4-hydroxy-2-
hexenal (HHE) and 4-oxo-2-hexenal (OHE). Long et al. (2008) found HHE to be toxic to 
cerebral cortical neurons, supporting the reported correlation between neurodegenerative 
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diseases and oxidized brain DHA. Rats given 4-oxo-2-hexenal intragastrically for five weeks had 
significantly higher rates of mortality compared to control rats (Takasu et al. 2007). Awada et al. 
(2012) fed mice a high fat diet containing HHE and found an increased presence of HHE in the 
serum and an enhancement of both proinflammatory markers and nuclear factor kappa-β.  
One of the largest effects of lipid oxidation products observed is their potential 
genotoxicity (for review see Ecki and Bresgen 2017). Thermally oxidized fish oil was observed 
to have skin cancer tumor initiating activity and slight tumor promoting activity when applied to 
the skin of mice (Pandey and Das 2006). In addition, HHE and 2-hexenal were both found to 
induce mutations in the Ames test (Grúz et al. 2017). OHE was found in DNA adducts in human 
autopsy tissues and may be a source of mutations which could contribute to cancer formation 
(Chou et al. 2010). After oral OHE administration to mice, Kawai et al. (2010) found an increase 
in the amount of DNA adducts detected in the stomach and large intestine. These results suggest 
adduct formation occurred from direct exposure to the stomach and large intestine as adducts 
were not found in the liver (Kawai et al. 2010).  
 Thus, one of the potential causes of the variability between omega-3 dietary enrichment 
studies may be that the oil is oxidized prior to feeding, herby lessening, negating, or even 
reversing any potential benefit that could be obtained by omega-3 fatty acid consumption. Albert 
et al. (2015) measured lipid oxidation in 32 different commercially available fish oil supplements 
that were within their “best-before” consumption date and compared them to international 
standards for fish oil supplements. These voluntary safety standards, as set by the Global 
Organization for EPA and DHA Omega-3s and the Council for Responsible Nutrition, and 
International Fish Oil Standards (IFOS), can be defined as a hydroperoxide value lower than 5 
mEq/kg, anisidine value lower than 20 mEq/kg or a total oxidation products measurement 
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(Totox) lower than 26 mEq/kg (Jackowski et al. 2015). Albert et al. (2015) found that 83% of the 
fish oil supplements exceeded recommended levels of hydroperoxide value and 50% exceeded 
the recommended Totox levels. Similarly, Mason and Sherratt (2017) investigated the three top 
selling fish oil dietary supplements in the United States of America and found that hydroperoxide 
value, anisidine value, and Totox levels exceeded the maximum levels established by 
international standards. Even if the amount of oxidation products in the oil before the start of a 
study is low, the oxidation could occur during the storage of the animal diets during the 
experimental time frame, which is often greater than 9 weeks. As an example of the oxidative 
susceptibility of omega-3 fatty acids, oil-in-water emulsions have been shown to oxidize in 6 
days at 32°C (Johnson et al. 2016).  
The objective of this study was to determine the susceptibility of omega-3 fatty acids to 
oxidation in a typical animal feed. In these studies, good quality oils, with low amounts of 
oxidation products were added to powdered animal feed and oxidation was monitored during 
storage.  The influence of different storage conditions and antioxidant treatments were evaluated 
to determine effective strategies to control oxidation. Thus, the overall goal of this study was to 
provide techniques by which omega-3 fatty acid investigators may strengthen their findings by 
reducing the presence of lipid oxidation products in their studies, therefore allowing for a greater 
focus on the biological effects of omega-3 fatty acids.   




 Modified AJN-93G Purified Rodent Diet was obtained from Dyets Inc. (Bethlehem, PA) 
and fish oil was obtained from DSM Nutritional Products LLC, 1B1/X1.2/250/13 /F/ BVT 
202131/TOU (Columbia, MD) and stored at -80C until use. The fatty acid composition was 
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found to be 6.73% C14:0, 1.08% C15:0, 19.65% C16:0, 8.15% C16:1, 0.89% C17:0, 4.33% 
C18:0, 17.97% C18:1 n9, 2.47% C18:1 n7, 2.38% C18:2 n6, 1.27% C18:3 n3, 1.81% C18:4 n3, 
0.88% C20:0, 1.02% C20:1, 0.77% C20:4 n6, 9.27% C20:5 n3, 0.80% C22:1, and 12.56% C22:6 
n3 by gas chromatography (Floch et al. 1997, Park et al. 2001). Menhaden fish oil was purchased 
from Sigma-Aldrich (St. Louis, MO).  
Propanal, trichloroacetic acid (TCA), ascorbyl palmitate, and tert-butylhydroquinone 
(TBHQ) were purchased from ACROS Organic (Morris Plains, NJ). Methanol, ethanol, hexane, 
ascorbic acid, and chloroform were obtained from Fisher Scientific (Waltham, MA). 2-
Thiobarbituric acid (TBA), ammonium thiocyanate, barium chloride, iron (II) sulfate 
heptahydrate, hydrochloric acid, propyl gallate (PG), butylhydroxy toluene (BHT), α-tocopherol, 
mixed tocopherols, 6-hydroxy-2,5,7,8-tetra-methylchromane-2-carboxylic acid (Trolox), 
1,1,3,3-tetraethoxypropane (TEP), dioxane and cumene hydroperoxide, were bought from 
Sigma-Aldrich (St. Louis, MO). High purity nitrogen and nitrogen/oxygen gas blends (5.0 and 
2.5 mol% oxygen in nitrogen) were obtained from AirGas Specialty Gases (Radnor, PA). 
Oxygen sensing patches were obtained from Ocean Optics Inc., 2015 (Dunedin, FL). Double 
distilled water was used to prepare all solutions and all solvents and reagents were of analytical 
grade or higher. 
 
3.2.2 Sample Preparation 
 
 Samples were prepared via mixing 85% rodent feed and 15% fish oil by mass. One-gram 
samples were stored in acid-washed, 10-ml glass gas chromatograph (GC) vials (Supelco 
Analytical; Bellefonte, PA), closed with aluminum screw caps containing PTFE/silicone septa 
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(Supelco Analytical; Bellefonte, PA) and stored at -20 to 37ºC in the dark, unless otherwise 
stated. 
 
3.2.3 Measurement of Lipid Oxidation Products 
 
3.2.3.1 Hydroperoxide Analysis 
 
Hydroperoxide concentrations were measured with a procedure adapted from Shantha 
and Decker (1994). Samples (0.1 g) were placed into a test tube and vortexed with 10 mL of 
chloroform:methanol (2:1 v/v) . The samples were centrifuged at 2,500 rpm for 10 minutes and 
0.2 mL of the supernatant was placed in a new test tube and mixed with 3.14 mL of the 
chloroform-methanol solvent, after which 34.5 µL a 1:1 solution of 0.144 mM ferrous sulfate in 
water and 0.132 M barium chloride dissolved in 0.4 N hydrochloric acid was added alongside the 
same volume of 3.94 M ammonium thiocyanate. After 20 minutes, spectrophotometric analysis 
was performed at 500 nm on a Genesys 20 spectrophotometer (ThermoSpectronic; Waltham, 
MA). Hydroperoxide concentration was calculated using a cumene hydroperoxide standard 
curve.  
 
3.2.3.2 Headspace Propanal Analysis 
 
 One gram of sample in the aforementioned glass gas chromatograph vials were analyzed 
using a GC2010 Plus Gas Chromatograph (GC) (Shimadzu; Kyoto, Japan). After samples were 
incubated at 45ºC for 10 minutes, a 50/30 um divinylbenzene/carboxen/polydimethylsiloxane 
(DVB/CAR/PDMS) Stableflex solid phase microextraction (SPME) fiber (Supelco Analytical; 
Bellefonte, PA) was exposed to the sample headspace for 2 minutes. The volatiles were desorbed 
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for three minutes in the GC injector at 250ºC at a split ratio of 1:7. Volatile compounds were 
separated using an Equity-1 fused-silica capillary column (30 m × 0.32 mm i.d. × 1 μm) coated 
with 100% polydimethylsiloxane (Supelco Analytical; Bellefonte, PA). The flame ionization 
detector was set to 250ºC while the oven was at 65ºC. The sample run time was 10 minutes and 
the peak for propanal was found at 1.6 minutes. Peak integration was calculated using Shimadzu 
Lab Solutions version 5.87 (2016).  
 A standard curve was created using fresh feed samples spiked with propanal in order to 
calculate the concentrations.  
 
3.2.3.3 Thiobarbituric Acid Reactive Substances Analysis 
 
 The Thiobarbituric Acid Reactive Substances (TBARS) assay was used as a method for 
secondary oxidation products, using a procedure adapted from (Johnson et al. 2016). Two mL of 
TBA reagent (15%, w/v TCA, 0.375%, w/v TBA in 0.25 M HCl mixed with 2% w/v BHT in 
ethanol) was added to 1 gram of sample. The mixture was suspended in 10 mL of water and after 
15 minutes of room temperature incubation, the sample was filtered using Whatman 4 qualitative 
circles (Sigma-Aldrich; St. Louis, MO). The filtrate was stored in the dark at room temperature 
for 24 hours to allow for the reaction of TBA with the oxidation products before measuring the 
absorbance at 532 nM on a Genesys 20 spectrophotometer (ThermoSpectronic; Waltham, 61 
MA).  
 A standard curve was created using fresh samples spiked with 1,1,3,3 tetraethoxypropane 




3.2.4 Impact of Temperature on Lipid Oxidation Rates 
 
 Samples were mixed and stored in triplicate as described above and stored in the GC 
vials at 37ºC, 23ºC, 4ºC and -20ºC in the dark. The sample stored at 37ºC was measured for 
oxidation products every day, 23ºC every other day, and 4ºC and -20ºC once a week.  
 
3.2.5 Impact of Oxygen Removal on Lipid Oxidation 
 
 Samples were stored in acid washed crimp cap glass vials with teflon/rubber septa 
(ThermoFischer Scientific; Rockwood, TN) and in the dark at 37ºC. Crimp cap vials were used 
in these experiments as they are more oxygen impermeable than screw capped vials. Oxygen 
sensing fluorescent patches (Ocean Optics Inc.; Dunedin, FL) were placed in the headspace of 
the vial and used to measure oxygen concentration, following a similar method to Johnson et al. 
(2016). Oxygen was removed by flushing the vials with nitrogen or nitrogen/oxygen blends for 3 
minutes before crimping the vials closed. Oxygen concentration, expressed as the percentage of 
oxygen removal compared to atmospheric oxygen, was measured every day along with lipid 
hydroperoxides and TBARS.  
 
3.2.6 Rate of Oxygen Removal 
 
 Feed samples were placed into a 5" x 8.25" vacuum sealable bag (Winpack; Winnipeg, 
Canada). The florescent patches, mentioned previously, were used to measure oxygen 
concentration both in the headspace and the section of the bag that contained sample. Nitrogen 
(>99%) was introduced through silicone tubing (5 mm diameter; MasterFlex, Gelsenkirchen, 
Germany) to flush the headspace at the maximum flow rate that did not cause the sample to be 
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blown into the air, approximately 2 L/min. The percent of oxygen removal was recorded every 5 
seconds. 
 
3.2.7 Impact of Antioxidants on Lipid Oxidation 
 
 Triplicate samples were mixed in triplicate with 200 µmoles of the respective antioxidant 
per kg of sample. The antioxidants tested included BHT, TBHQ, PG, α-tocopherol, mixed 
tocopherols, Trolox, ascorbic acid and ascorbyl palmitate. Every day, after storage at 37ºC in the 
dark in the aforementioned capped gas chromatograph vials, lipid hydroeroxide, headspace 
propanal, and TBARS concentrations were measured.  
  
3.2.8 Statistical Analysis  
 
One-way analysis of variance (ANOVA) followed by Tukey’s pairwise comparison was 
conducted in order to determine statistical significance. The calculations were performed using 
Minitab 18.1 Statistical Software. All samples were run in triplicate. Lag phase was determined 
as the period before which there is no significant change in oxidation product amount.  
 
3.3 Results and Discussion 
 
Fifty published papers from the past five years on the evaluation of dietary omega-3 fatty 
acids in animal studies were reviewed, and these studies and their methods of oxidation control 
are summarized in Table 1. Of these 50 papers, 35 did not mention any form of oxidation 
control. The most common method of control used in the literature was through temperature, 
storing omega-3 enriched feed at -20ºC or below, with 8 of the 50 sources mentioning these 
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storage conditions. Three studies used encapsulation of the oil as their primary method of 
control. Kemese et al. (2014) used previously encapsulated oil, MaxEPA (Merck Darmstadt, 
Germany), Eilati et al. (2013) filled fish oil into gelatin capsules, and Coulombe et al. (2018) 
used oil that was microencapsulated by DSM Nutritional Products (Columbia, MD). No data was 
provided on the effectiveness of encapsulation on oxidative stability during storage. Only 3 
studies enriched the diets with antioxidants to inhibit oxidation. Njoroge et al. (2015) used 
vitamin A, vitamin C, vitamin E, and selenium. Madingou et al. (2016) used unspecified 
antioxidants during feed preparation, and the oil used by Thang et al. (2013) contained TBHQ. In 
the studies that used oxidation control strategies, no data to verify the effectiveness of these 
methods was presented.  Only 1 of the 50 studies described measuring lipid oxidation at any 
point in the study and did so in the form of hydroperoxides at the beginning of the feeding study 
(Ostermann et al. 2017). As the amount of toxic oxidation product formation in the majority of 
these studies is unknown, their effect may be the confounding factor leading to differing results.  
 
3.3.1 Oxidation Products in Commercially Available Fish Oils 
 
Menhaden oil from Sigma and the fish oil from DSM Nutritional Products had 
hydroperoxide values lower than the limit of detection, 0.2 mmoles hydroperoxide/ kg sample, 
when analyzed on freshly received samples. Menhaden oil had significantly more headspace 
propanal, indicating that the menhaden oil was more oxidized than the fish oil (Figure 1).  Lipid 
hydroperoxides are unstable and thus may have decomposed during storage or they may have 
been decreased during refining operation steps, such as steam distillation (Decker et al. 2012). 
Therefore, even though an oil can have low hydroperoxides, the presence of other oxidation 
products, such as propanal, indicates that the menhaden oil was rancid.  Balogun et al. (2013) 
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used menhaden fish oil from Sigma in their research on omega-3 enrichment in mice without 
mentioning any measurements of lipid oxidation products or methods of lipid oxidation control, 
and thus may have used oxidized oil. The presence of lipid oxidation products in the commercial 
products, such as menhaden oil, suggests that some investigators could be starting with oxidized 
oils.     
 
3.3.2 Impact of Temperature on Lipid Oxidation 
 
It has been well documented that lipid oxidation decreases significantly with decreasing 
temperature (Gómez-Alonso et al. 2004, Ragnarsson and Labuza 1977). For example, in 
spaghetti enriched with fish oil, Verardo et al. (2009) found that one day of storage at 55ºC 
caused an equivalent level of lipid oxidation to 18 days of storage at room temperature. In 
crackers, another low moisture food, a reduction of temperature from 35°C to 25°C increased the 
lag period from 10 weeks to 17 (Berenzon et al. 1998).  Even though temperature reduction is 
practical method to inhibit lipid oxidation only 8 of the 50 animal studies reviewed mentioned 
using this precaution in their studies. 
Figure 2 shows that under frozen storage at -20°C, neither lipid hydroperoxides nor 
headspace propanal were significantly higher than day 0 values after 63 days of storage.  
Refrigeration storage was also quite effective, with neither lipid hydroperoxides nor headspace 
propanal becoming significantly higher than day 0 values until day 49 and 56 days of storage, 
respectively.  The lag phase for lipid hydroperoxide formation was shorter than propanal 
formation, which can be explained by the fact that propanal is formed from the decomposition of 
lipid hydroperoxides.  Such large differences in the lag phases of lipid hydroperoxide and 
aldehyde formation has also been observed in a cracker model system and has been postulated to 
be due to the low diffusion and thus low reactivity of metals in low moisture systems (Barden et 
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al. 2015b).  Both lipid hydroperoxide and propanal formation were extremely rapid at 37°C, with 
a lag phase of 2 days. At 23°C, the lag phases of lipid hydroperoxide and propanal formation 
were longer, at 6 and 8 days, respectively.  The rapid oxidation observed at 23 and 37°C suggests 
that oxidation products could be formed during the course of a feeding study, especially if 
ambient temperature gets above 23°C since most feeding studies exceed one week (Table 1). 
 
3.3.3 Impact of Oxygen Reduction on Lipid Oxidation 
 
 Oxygen is an essential substrate for lipid oxidation as its bi-radical nature allows for the 
rapid formation of peroxyl radicals upon interaction with alkyl radicals.  The alkyl radical-
oxygen radical reaction rates are close to diffusion limited and thus only small amounts of 
oxygen are needed to promote lipid oxidation (For review, see Johnson and Decker 2015).  
Despite this, the positive effect of oxygen removal has been observed in other low moisture 
systems. In hazelnuts stored under 99% nitrogen and 1% oxygen, Ghiradello et al. (2013) found 
that the modified atmosphere reduced hydroperoxide value by 78% after 12 months of storage 
compared to a control with atmospheric oxygen. Reduction of oxygen (<1% oxygen) through the 
use of oxygen absorbers has been shown to increase the lag phase of crackers to past 44 weeks, 
compared to 17 weeks at atmospheric oxygen (Berenzon et al. 1998). Marasca et al. (2016) 
found that potato crisps had 30% lower hydroperoxide concentrations at 4 weeks of storage and 
91% lower headspace hexanal at 5 weeks of storage when stored under nitrogen with a residual 
oxygen content below 2% compared to chips stored under ambient conditions. Jensen et al. 
(2011b) found that storing whole wheat bread in vacuum bags with nitrogen as the filler gas 
caused a “small, but significant” increase in oxidative stability. Thus, oxygen reduction has been 
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shown to reduce lipid oxidation in low moisture systems, although the effects have been 
observed almost exclusively with high degrees of oxygen removal.  
In this study, headspace vials and nitrogen-oxygen blends were used to create 55, 65 and 
80% reduced oxygen headspace conditions.  The results of the storage study at 37°C are shown 
in Figure 3. The control sample (atmospheric oxygen) had a lag phase of 3 days, both as 
measured by lipid hydroperoxides and TBARS (headspace propanal could not be measured 
because the septum in the crimped vials could not be penetrated by the SPME needle). Reduction 
of oxygen to 55% increased the lipid hydroperoxide lag phase by a day but caused no change to 
the TBARS lag phase. Reduction of oxygen to 65% produced a lag phase of 5 days for both lipid 
hydroperoxides and TBARS while 80% oxygen removal led to a lag phase of 9 days for both 
lipid hydroperoxides and TBARS.  
 It is therefore possible that the lag phase of lipid oxidation product formation could be 
extended by oxygen removal if investigators flushed the feed with nitrogen long enough to get at 
least 65% oxygen reduction and stored samples in airtight containers. To determine if this was 
feasible, nitrogen was flushed into vacuum sealable bags containing fish oil enriched feed. 
Oxygen levels were determined using oxygen sensitive patches that were located in the 
headspace and within the feed.   Headspace oxygen decreased rapidly, achieving 90% oxygen 
reduction within 5 seconds (Figure 4). Oxygen levels within the feed took 20 seconds to reach 
75% oxygen removal after which no further statistically significant reduction was reached. This 
is a much faster rate of oxygen removal than seen in oil-in-water emulsions, where it takes a 
significant time (>60 minutes) to remove 65% of the total oxygen by nitrogen flushing (Johnson 
et al. 2016). This suggests that oxygen removal could be a viable method to slow lipid oxidation 
rates as long as the packaging material is oxygen impenetrable and oxygen does not reenter the 
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feed during storage. Container type is an important consideration if this antioxidant strategy is 
applied as Ziplock bags, which are made of either low or high-density poly(ethylene), have been 
shown to have an oxygen transmission rate of 6509 cm3/m2day (Rhee et al. 1999), compared to 
0.36 cm3/m2day for vacuum packaging bags (López-Rubio et al. 2005) meaning that oxygen 
could be reintroduced into the feed during storage.   
 
3.3.4 Impact of Antioxidants on Lipid Oxidation 
 
 Antioxidants are a viable method to control lipid oxidation however, many antioxidants 
have biological activity (e.g. tocopherols) so they could make data interpretation more difficult 
and thus may not be suitable to protect omega-3 fatty acids in animal studies.  Metal chelators 
are not strong antioxidants in low moisture systems, presumably due to the lack of reactivity of 
transition metals due to their low mobility (Barden et al. 2015b).  Free radical scavenging 
antioxidants display varying levels of effectiveness due to differences in their ability to scavenge 
free radicals, the energy level of the resulting antioxidant radical which can impact promotion of 
oxidation, their reducing potential which can reduce transition metals and increase prooxidant 
activity, and their polarity which can impact their partitioning into the lipid and thus their ability 
to interact with lipid radicals (McClements and Decker 2000).  Therefore, several classes of 
antioxidants were tested to determine the properties of free radical scavenging antioxidants that 
would be most effective in animal feed. 
Tocopherols and Trolox are useful tools to determine how the polarity of antioxidants 
impact their ability to inhibit lipid oxidation in a food or feed system since both have similar free 
radial scavenging activity but very different polarities.  Both hydrophobic α-tocopherol and a 
commercially available mixture of tocopherols homologs (mixed tocopherols) were not very 
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effective at inhibiting lipid oxidation in the feed as determined by lipid hydroperoxides, TBARS, 
and headspace propanal (Figure 5). Conversely, Trolox was a much more effective antioxidant 
with lipid hydroperoxides, TBARS, and headspace propanal not exiting the lag phase for the 8-
day duration of the storage study. Trolox has been reported to be more effective in bulk oils than 
tocopherols (Frankel 1996).  In the feed system used in these studies, oil was mixed into a dried 
feed with no further processing.  The oil is simply distributed in the dry powder and thus may 
have properties of a bulk oil, explaining why Trolox was observed to be more effective than 
tocopherols.  
Ascorbic acid and ascorbyl palmitate also have similar free radical scavenging activity 
and different polarities but differ in that their reducing potential is much greater than phenolic 
antioxidants and thus can sometimes led to prooxidant activity by metal reduction (Mäkinen et 
al. 2001). Ascorbic acid was not able to substantially inhibit lipid hydroperoxides, TBARS and 
headspace propanal formation (Figure 6). Ascorbyl palmitate slightly increased lipid 
hydroperoxide formation lag by 1 day and was not able to change the lag phase of headspace 
propanal formation or TBARS formation.  Overall, ascorbic acid and ascorbyl palmitate were 
much less effective than Trolox, possibility due to their ability to promote oxidation. 
Synthetic antioxidants such as propyl gallate (PG), TBHQ and BHT can also be used to 
inhibit lipid oxidation.  These antioxidants differ in polarity, PG>TBHQ>BHT (most to least 
polar).  The results of the comparison between PG, TBHQ and BHT are shown in Figure 7. 
Overall, propyl gallate was ineffective or prooxidative, reducing the lag phase by 1 day for lipid 
hydroperoxides, TBARS, and headspace propanal compared to the control.  BHT did not change 
the lag phase for lipid hydroperoxides but increased the lag phase for TBARS by 3 days, and the 
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headspace propanal lag phase increased by 1 compared to the control. Samples containing TBHQ 
did not exit lag phase for the 10-day duration of the study.  
These results are similar to those found in other low moisture food systems. In fried fish 
crackers, Ahmad and Augustin (1985) found that incorporation of TBHQ into either the cracker 
dough and the frying medium were able to reduce the rate of lipid oxidation. Sharma et al. 
(1997) treated fried potato crisps, banana chips and fried Bengalgram dhal with butylated 
hydroxyanisole (BHA), BHT and TBHQ. BHA provided the least protection while TBHQ 
provided the most. Barden et al. (2015a) found that in a model cracker system, antioxidant 




A potential explanation for the conflicting research in the field of omega-3 
supplementation in animals is the presence of potentially toxic lipid oxidation products and a 
lack of control of lipid oxidation during storage of feeds. The majority of omega-3 animal 
feeding studies over the past 5 years do not provide information on what, if any, measures were 
taken to control the formation of toxic lipid oxidation products, nor do they assess the initial 
oxidative status of the oils. This study demonstrated that oxidation of omega-3 fatty acids in 
animal feed can occur under conditions commonly used for the storage of animal feed.   
Researchers performing omega-3 animal feeding studies have several options to 
minimize the presence of lipid oxidation products in their studies.  First, they should insure that 
the starting oils are of very high quality and has low levels of both primary (e.g. hydroperoxides) 
and secondary (e.g. aldehydes).  For example, Global Organization for EPA and DHA Omega-
3s, the Council for Responsible Nutrition, and International Fish Oil Standards (IFOS), define 
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acceptable oxidation levels as a hydroperoxide value lower than 5 mEq/kg, anisidine value lower 
than 20 mEq/kg and a total oxidation products measurement (Totox) lower than 26 mEq/kg 
(Jackowski et al. 2015). Even if an investigator starts with a high-quality oil, they must ensure 
that it does not decompose during storage.  This can be done by keeping the high-quality oil or 
oil fortified feed at refrigeration temperatures for studies under 30-35 days and at least -20°C for 
longer studies. If the oil is kept under optimum conditions, one option to insure high quality is to 
prepare the feed daily.  If this cannot be done, the feed can be refrigerated or frozen depending 
on the length of the feeding study.  Alternately, the feed can be stored under reduced oxygen (at 
least 65% reduction) and stored in low oxygen permeable packaging or be treated with 
antioxidants. Both Trolox and TBHQ were the most effective antioxidants among those tested. 
Investigators may wish to be cautious about preserving the feed with antioxidants as the 
antioxidant could have biological implication in their feeding study and the antioxidant 
concentration in the feed will decrease during storage as they are consumed by lipid radicals.  
While this study provides some guidelines for the optimal conditions for storage of 
omega-3 fortified animal feed, investigators should be aware that other components incorporated 
into the feed could impact oxidation rates.  Compounds such as metal, free fatty acids, 
carotenoids, singlet oxygen generators (e.g. riboflavin), and components that impact water 
activity (e.g. sugars and salts) will impact lipid oxidation rates.  In these situations, as well as a 
precaution in all omega-3 feeding studies, investigators should monitor lipid oxidation rates in 
both the starting oil and during storage of the feed.  Both primary and secondary oxidation 
products should be monitored since there are situations where one marker could be low (e.g. in 
situations where lipid hydroperoxides stability is low) and provide misleading evidence that 




3.5 Future Directions 
 
 Further research is needed to elucidate the optimal conditions for lowering lipid oxidation 
in omega-3 enriched feed for animal studies. Antioxidants and oxygen reduction used in 
combination may show a synergistic effect in lowering lipid oxidation and warrant further study. 
A benefit to synergism is that less antioxidant overall is needed, potentially lowering their 
confounding impact in test animals. Other methods of oxygen reduction, such as scavengers and 
vacuum, should be researched as well. One of the negatives of nitrogen flushing is that it is not 
practical for removing all of the oxygen in a system, especially in porous samples. In their 
research of modified atmosphere and potato crisps, Silva et al. (2004) found that an oxygen 
scavenger was more effective than nitrogen headspace at reducing lipid oxidation at 3 months of 
storage. Finally, while this research was performed in dry powder, experimental animal feed is 
also found in the form of extruded pellets.  Providing feed in pellet form opens up different 
opportunities for inhibiting lipid oxidation. Pellets, unlike dry powder, can be encapsulated in 
films. Food films can provide protection against lipid oxidation by providing an oxygen 
impermeable membrane or can contain antioxidants themselves. But, extruded pellets are also 
porous, which would make removing oxygen through nitrogen flushing less efficient. 
Encapsulation of the oil is another method through which oxidation may be reduced and has 
been used in some of the recent literature.  Future research should delve into other antioxidants, 
alternative methods of oxygen reduction, and other physical forms of feed and combination of 






TABLE AND FIGURES 
Table 1: Methods of Oxidation Control in Published Dietary Omega-3 Enrichment Animal 
Studies 
Citation Animal Enrichment Control Study Length Rate of 
refreshmen
t of feed 
Madingou et al. 
2016 
Rat EPA and DHA Antioxidant 
addition 
2 weeks N/A 
Njoroge et al. 
2015 
Mouse emulsion 
form, 2.4 g/L 




2 weeks Daily 
Kemse et al. 
2014 
Rat Fish Oil Encapsulation 3 weeks N/A 
Eilati et al. 2013 Hens Fish Oil Encapsulation in 
gelatin 
3 weeks N/A 
Ostermann et al. 
2017 
Mouse EPA and DHA 
as ethyl esters 
Measurement of 
Peroxide Value, 
Storage at -20°C 
5 weeks 2-3 days 




40 weeks N/A 
Ross et al. 2016 Rat EPA, and/or 
DHA 
Storage -20°C 8 weeks N/A 
Diest et al. 2015 Rat Tuna Oil Storage at −20°C 4 weeks 7 days 
Koivisto et al. 
2014 
Mouse Fish Oil Storage at -20°C 32 weeks N/A 
Li et al. 2017 Mouse ALA Storage at -20°C 8 weeks N/A 
Maditz et al. 
2014 
Rat ALA, salmon 
oil 
Storage at -20°C 12 weeks Daily 
Bates et al. 2016 Mouse Microalgal Oil 
containing 
DHA 
Storage at -20°C, 
new feed mixed 
biweekly, TBHQ 
17 weeks 2 days 
Figueroa et al. 
2014 
 Rat Fish Oil Storage at 4°C 8 weeks N/A 
Tillander et al. 
2014 
Mice Fish Oil or 
Krill Oil 
Storage in airtight 
bags and frozen 
until use 
6 weeks N/A 




Storage in Ziploc 
bags at –80°C, 
TBHQ 
10 weeks Daily 
Assis et al. 2015 Rat Fish Oil N/A 4 weeks N/A 
Balogun et al. 
2013 
Mouse Menhaden 
Fish Oil  
N/A 16 weeks 2 days 
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Bernhard et al. 
2016 
Mouse Marine Oils N/A 4 weeks 3 times per 
week 
Caron et al. 
2015 
Mouse DHA and EPA N/A 5 weeks N/A 
Castellano et al. 
2014 
Pig Conjugated 
ALA or n-3 
fatty acids 
N/A 17 days N/A 
Cheshmehkani 
et al. 2015 
Rat Fish Oil N/A 8 weeks 7 days 
Dasilva et al. 
2017 
Rat Fish Oil N/A 25 weeks N/A 
Dehkordi et al. 
2015 
Rat omega-3 fatty 
acids 
N/A 30 days Daily 
Dinnetz et al. 
2013 
Horse EPA and DHA N/A 8 weeks N/A 
Enos et al. 2015 Mouse Multiple 
sources of fat 
N/A 20 weeks N/A 
Fink et al. 2014 Rat Walnut Oil N/A 10 weeks N/A 
Freitas et al. 
2016 
Mouse Fish Oil N/A 3 weeks N/A 
Fu et al. 2015 Mouse Omega-3 or 
Omega-6 fatty 
acids 
N/A 17 days N/A 








N/A 4 weeks 7 days 
Henderson et al. 
2014 
Mouse Oleic Acid or 
ALA 
N/A 5 weeks 8 days 
Jacometo et al. 
2014 
Rat Flaxseed Oil  N/A 3 weeks N/A 
Janssen et al. 
2015 
Mouse ALA and/or 
DHA 
N/A 60 days N/A 
Jones et al. 2013 Rat Omega-3 
Long Chain 
Fatty Acids 
N/A 3 weeks N/A 
Jump et al. 2015 Mouse DHA or EPA N/A 16 weeks N/A 
Kemse et al. 
2016 
Rat Omega-3 Fatty 
Acids  




Mouse Fish Oil N/A 32 weeks N/A 
MacLennan et 
al. 2013 
Mouse Menhaden Oil N/A 3 weeks N/A 
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Mark et al. 2014 Rat Omega-3 
Long Chain 
Fatty Acids 
N/A 21 weeks N/A 
Pietropaolo et al. 
2014 
Mouse Tuna Oil N/A N/A N/A 
Shoda et al. 
2015 
Mouse  Omega 3 or 6 
Long Chain 
Fatty Acids 
N/A 4 weeks N/A 
Sopian et al. 
2015 
Mouse Fish Oil N/A 3 weeks N/A 
Su et al. 2016 Mouse Flaxseed Oil N/A 14 weeks N/A 
Trevizol et al. 
2013 
Rat  Fish Oil N/A 90 days N/A 




N/A 16 weeks 2-3 days 
Vigerust et al. 
2013  
Mouse Krill Oil N/A 6 weeks N/A 
Wandersee et al. 
2015 
Mouse DHA N/A 8 weeks N/A 
Wang et al. 2013 Rat Fish Oil N/A 6 weeks N/A 
Yip et al. 2013 Mouse EPA N/A 8 weeks N/A 
Zarei et al. 2016 Rat Omega-3 Fatty 
Acid  
N/A 4 weeks Daily 
Zulkafli et al. 
2013 
Rat Omega-3 Fatty 
Acid 


















Figure 3:  Hydroperoxide Value (A) and Thiobarbituric Reactive Substances (B) of 












Figure 5: Hydroperoxide Value (A), Headspace Propanal (B), and Thiobarbituric Reactive 








Figure 6: Hydroperoxide Value (A), Headspace Propanal (B), and Thiobarbituric Reactive 





Figure 7: Hydroperoxide Value (A), Headspace Propanal (B), and Thiobarbituric Reactive 
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